Fenbendazole Weefen 222 mg is an oral fenbendazole tablet manufactured by Weefsel Pharma. Fenbendazole belongs to the benzimidazole class of anthelmintic medicines and is primarily used in veterinary medicine for the treatment and control of susceptible parasitic worm infections.
Weefsel Pharma lists Weefen in several strengths, including 150 mg, 222 mg, 444 mg, 500 mg. The 222 mg formulation provides 222 mg of fenbendazole per tablet and is intended for veterinary use according to the applicable product information and professional guidance.
Fenbendazole is a broad-spectrum veterinary anthelmintic used for the treatment and control of certain anti parasitic worms. Depending on the animal species and product labeling, fenbendazole may be used against susceptible gastrointestinal parasites.
Fenbendazole may be used under veterinary guidance for susceptible parasites such as:
The appropriate treatment depends on the animal species, body weight, parasite involved and veterinary diagnosis.
Fenbendazole is sometimes discussed in preclinical and experimental cancer research. However, fenbendazole is not an FDA-approved human cancer treatment, and evidence from laboratory or animal studies should not be interpreted as proof that it treats cancer in people.
It should not be promoted as a replacement for approved cancer treatment. Anyone considering experimental use should discuss the risks and available evidence with a qualified healthcare professional.
Fenbendazole belongs to the benzimidazole group of anthelmintic compounds. It acts on parasite cells by interfering with tubulin and microtubule formation. This can interfere with important cellular processes needed for parasite survival and energy metabolism.
The exact effects can vary depending on the parasite and animal species. Veterinary treatment should therefore follow the applicable product instructions or veterinary advice.
For this reason, the 222 mg tablet should not be dosed simply according to the tablet strength. Follow the manufacturer's veterinary directions or the dosage provided by a veterinarian.
Do not use veterinary fenbendazole as a substitute for an approved human medicine.
Most animals tolerate fenbendazole when it is used appropriately, but side effects can occur.
If an animal develops persistent vomiting, severe diarrhea, marked weakness or another unusual reaction, contact a veterinarian.
Serious reactions are uncommon, but veterinary attention should be sought if an animal develops:
Prolonged or inappropriate use may also require additional veterinary monitoring.
Before giving fenbendazole, inform the veterinarian about any other medicines, supplements or veterinary treatments the animal is receiving.
Potential interactions can depend on the animal species and concurrent medicines. Avoid combining antiparasitic products without professional advice.
For human use, fenbendazole should not be assumed to be safe with prescription medicines simply because it is available as a veterinary product.
Follow the specific instructions supplied with the veterinary product. Administration with food may be appropriate for some veterinary formulations, but the product label and veterinarian's instructions should take priority.
Make sure the animal has access to adequate water and follow any feeding instructions provided as part of its treatment plan.
Routine monitoring is not required for every short veterinary treatment, but additional monitoring may be appropriate for animals receiving repeated or prolonged treatment or those with underlying health problems.
A veterinarian may recommend clinical monitoring or laboratory testing when appropriate.
Do not independently use liver-function testing or other medical monitoring as a reason to undertake an unapproved human treatment regimen.
The product is a veterinary formulation. It should not be presented as an approved human medicine or used for self-treatment without appropriate medical direction.
No. Fenbendazole is not FDA-approved as a cancer treatment for humans. Experimental and preclinical research should not be confused with established clinical treatment.
The appropriate veterinary dose depends on the animal species, body weight, parasite and treatment plan. A veterinarian should determine the appropriate dose.
Possible veterinary side effects include digestive upset, reduced appetite, vomiting and diarrhea.
Potential interactions depend on the animal and other medicines being used. Always tell the veterinarian about all current medicines and supplements before treatment.
Store the product according to the manufacturer's instructions on the packaging and keep it out of reach of children and animals for which it is not intended.
| Pack Size | Price |
|---|---|
| 100 Tablet/s | $80.00 |
| 200 Tablet/s | $140.00 |
| 300 Tablet/s | $190.00 |
| 500 Tablet/s | $350.00 |
| 1000 Tablet/s | $580.00 |
Medical Disclaimer: The information on this site is for educational purposes only. Consult a licensed healthcare professional before starting, stopping, or changing any medication.
Reviews
There are no reviews yet.